Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTU
2301
Optimum Communications Inc
OPTU
$343M
| $3.76M | ﹤0.01% |
1,527,424
+834,030
| +120% | +$1.61M |
|
2302
Payoneer
PAYO
$2.41B
| $3.76M | ﹤0.01% |
498,727
+388,584
| +353% | +$2.52M |
|
2303
Boston Beer
SAM
$1.92B
| $3.76M | ﹤0.01% |
12,988
+3,983
| +44% | +$1.11M |
|
2304
Cheesecake Factory
CAKE
$5.26B
| $3.75M | ﹤0.01% |
92,512
+63,217
| +216% | +$2.41M |
|
2305
Warby Parker
WRBY
$3.67B
| $3.75M | ﹤0.01% |
229,356
+171,988
| +300% | +$2.59M |
|
|
RBCP
2306
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $3.74M | ﹤0.01% |
28,215
+3,215
| +13% | +$413K |
|
2307
Amalgamated Financial
AMAL
$1.49B
| $3.74M | ﹤0.01% |
119,165
+57,008
| +92% | +$1.73M |
|
2308
PUT
Kroger
KR
$35.4B
| $3.72M | ﹤0.01% |
+65,000
| New | +$3.49M |
|
2309
Pathward Financial
CASH
$1.89B
| $3.72M | ﹤0.01% |
56,327
+25,570
| +83% | +$1.64M |
|
2310
PUT
Williams-Sonoma
WSM
$29.3B
| $3.72M | ﹤0.01% |
+24,000
| New | +$3.44M |
|
2311
Huron Consulting
HURN
$2.43B
| $3.71M | ﹤0.01% |
34,156
-4,613
| -12% | -$489K |
|
2312
NCR Atleos
NATL
$3.47B
| $3.71M | ﹤0.01% |
130,115
+104,488
| +408% | +$3.04M |
|
|
RC
2313
Ready Capital
RC
$287M
| $3.7M | ﹤0.01% |
484,986
+326,467
| +206% | +$2.77M |
|
2314
CALL
Bristol-Myers Squibb
BMY
$135B
| $3.7M | ﹤0.01% |
71,500
-38,800
| -35% | -$1.82M |
|
2315
ProShares S&P 500 ex-Health Care ETF
SPXV
$40.7M
| $3.68M | ﹤0.01% |
60,000
| – | – |
|
2316
CALL
Coupang
CPNG
$30.1B
| $3.68M | ﹤0.01% |
150,000
| – | – |
|
2317
CALL
Linde
LIN
$223B
| $3.67M | ﹤0.01% |
7,700
-21,000
| -73% | -$9.58M |
|
|
JHG
2318
DELISTED
Janus Henderson
JHG
| $3.66M | ﹤0.01% |
96,217
+43,933
| +84% | +$1.59M |
|
|
AKRO
2319
DELISTED
Akero Therapeutics
AKRO
| $3.66M | ﹤0.01% |
127,668
+71,652
| +128% | +$1.87M |
|
2320
iShare MSCI Eurozone ETF
EZU
$9.85B
| $3.65M | ﹤0.01% |
69,841
+55,753
| +396% | +$2.79M |
|
2321
PUT
Pentair
PNR
$10.9B
| $3.65M | ﹤0.01% |
+37,300
| New | +$3.19M |
|
2322
CleanSpark
CLSK
$3.64B
| $3.64M | ﹤0.01% |
389,201
+305,316
| +364% | +$3.88M |
|
2323
SoFi Technologies
SOFI
$24.1B
| $3.64M | ﹤0.01% |
462,485
+23,766
| +5% | +$173K |
|
2324
First Commonwealth Financial
FCF
$2.22B
| $3.63M | ﹤0.01% |
211,797
+116,295
| +122% | +$1.91M |
|
2325
AtriCure
ATRC
$1.98B
| $3.62M | ﹤0.01% |
129,265
-174,803
| -57% | -$4.31M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.